Thane Kreiner
Vorstandsvorsitzender bei Marin Agricultural Land Trust
Profil
Thane Kreiner was the founder of Second Genome, Inc. founded in 2009 where he held the title of President & Chief Executive Officer.
Dr. Kreiner is also the founder of Presage Biosciences, Inc. Dr. Kreiner's current job is Chief Executive Officer at Marin Agricultural Land Trust since 2021.
Dr. Kreiner's former jobs include Chief Executive Officer at iZumi Bio, Inc. and Senior Vice President-Sales & Marketing at Affymetrix, Inc. Dr. Kreiner earned an MBA and a doctorate from Stanford University.
Aktive Positionen von Thane Kreiner
| Unternehmen | Position | Beginn |
|---|---|---|
| Marin Agricultural Land Trust | Vorstandsvorsitzender | 30.03.2021 |
Ehemalige bekannte Positionen von Thane Kreiner
| Unternehmen | Position | Ende |
|---|---|---|
| AFFYMETRIX, INC. | Vertrieb & Marketing | 27.07.2007 |
iZumi Bio, Inc.
 iZumi Bio, Inc. BiotechnologyHealth Technology iZumi Bio, Inc. develops and manufactures biotechnology products. It focuses on stem cell science and translating cell based technology to the drug discovery and development process. The company's solutions are used for disease research, preclinical drug testing, and cell-based therapies. Its therapies are used to treat the patients suffering from critical diseases. iZumi Bio was founded in 2007 and is headquartered in South San Francisco, CA. | Präsident | - |
Presage Biosciences, Inc.
 Presage Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Presage Biosciences, Inc. engages in development of novel drugs for treatment of cancers. It offers CIVO arrayed microinjection platform that allows for simultaneous assessment of multiple drugs or drug combinations directly in a single solid tumor while still in a patient’s body to assess efficacy, resistance, and drug synergies in the tumor’s native microenvironment. The company was founded by James M. Olson and Thane Kreiner in 2008 and is headquartered in Seattle, WA. | Gründer | - |
Second Genome, Inc.
 Second Genome, Inc. BiotechnologyHealth Technology Second Genome, Inc. develops microbiome-based therapeutic products. It offers phyclochip community, 16S sequencing community analysis, whole metagenomic profiling, nucleic acid isolation, inferred function and custom informatics services. The company was founded in 2009 by Corey S. Goodman, Janet A. Warrington, Todd Z. DeSantis, John Hulls and Gary Andersen and is headquartered in South San Francisco, CA. | Gründer | - |
Ausbildung von Thane Kreiner
| Stanford University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Affymetrix, Inc.
 Affymetrix, Inc. Medical SpecialtiesHealth Technology Affymetrix, Inc. develops, manufactures and sells products and services for genetic analysis. The company was founded by Stephen P. A. Fodor in 1992 and is headquartered in Santa Clara, CA. | Health Technology |
Presage Biosciences, Inc.
Presage Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Presage Biosciences, Inc. engages in development of novel drugs for treatment of cancers. It offers CIVO arrayed microinjection platform that allows for simultaneous assessment of multiple drugs or drug combinations directly in a single solid tumor while still in a patient’s body to assess efficacy, resistance, and drug synergies in the tumor’s native microenvironment. The company was founded by James M. Olson and Thane Kreiner in 2008 and is headquartered in Seattle, WA. | Health Technology |
| Marin Agricultural Land Trust | |
iZumi Bio, Inc.
iZumi Bio, Inc. BiotechnologyHealth Technology iZumi Bio, Inc. develops and manufactures biotechnology products. It focuses on stem cell science and translating cell based technology to the drug discovery and development process. The company's solutions are used for disease research, preclinical drug testing, and cell-based therapies. Its therapies are used to treat the patients suffering from critical diseases. iZumi Bio was founded in 2007 and is headquartered in South San Francisco, CA. | Health Technology |
Second Genome, Inc.
Second Genome, Inc. BiotechnologyHealth Technology Second Genome, Inc. develops microbiome-based therapeutic products. It offers phyclochip community, 16S sequencing community analysis, whole metagenomic profiling, nucleic acid isolation, inferred function and custom informatics services. The company was founded in 2009 by Corey S. Goodman, Janet A. Warrington, Todd Z. DeSantis, John Hulls and Gary Andersen and is headquartered in South San Francisco, CA. | Health Technology |
